US FDA advisers recommend against Otsuka's PTSD combination treatment – Reuters

1. US FDA advisers recommend against Otsuka’s PTSD combination treatment  Reuters
2. Otsuka, Lundbeck’s PTSD Bid for Rexulti Hits Speedbump as FDA Questions Efficacy  BioSpace
3. First New PTSD Drug in Two Decades On the Horizon?  Medscape
4. Don’t Look Back: US FDA AdComm Offers No Flexibility For Rexulti’s Post Hoc Bid In PTSD  insights.citeline.com
5. Psychiatric Times Experts Weight in on FDA Advisory Decision for PTSD  Psychiatric Times

Continue Reading